Form S-3 Foghorn Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Broadcom forecasts quarterly revenue below estimates
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Foghorn Therapeutics Inc. (FHTX) Files $300M Mixed Shelf
January 24, 2025 4:08 PM ESTFoghorn Therapeutics Inc. (NASDAQ: FHTX) has filed $300,000,000 mixed shelf of:
Common Stock
Preferred Stock
Warrants
Units
